skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Marine drugs for cancer: surfacing biotechnological innovations from the oceans
Marine drugs for cancer: surfacing biotechnological innovations from the oceans
Material Type:
Artigo 		Adicionar ao Meu Espaço

Marine drugs for cancer: surfacing biotechnological innovations from the oceans

Jimenez, Paula Christine; Wilke, Diego Veras; Costa-Lotufo, Leticia Veras

Clinics; v. 73 n. Suppl. 1 (2018); e482s

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo 2019-02-14

Acesso online

2
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Patel, Vaibhav G. ; Oh, William K. ; Galsky, Matthew D.

CA: a cancer journal for clinicians, 2020-09, Vol.70 (5), p.404-423 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
3
Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates
Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates

Kalim, Muhammad ; Chen, Jie ; Wang, Shenghao ; Lin, Caiyao ; Ullah, Saif ; Liang, Keying ; Ding, Qian ; Chen, Shuqing ; Zhan, Jinbiao

Drug design, development and therapy, 2017-01, Vol.11, p.2265-2276 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por
4
Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities
Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities

Spring, Laura M. ; Nakajima, Erika ; Hutchinson, Jennifer ; Viscosi, Elene ; Blouin, Gayle ; Weekes, Colin ; Rugo, Hope ; Moy, Beverly ; Bardia, Aditya

The oncologist (Dayton, Ohio), 2021-10, Vol.26 (10), p.827-834 [Periódico revisado por pares]

Hoboken, USA: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
5
Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody-Drug Conjugate
Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody-Drug Conjugate
Material Type:
Artigo 		Adicionar ao Meu Espaço

Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody-Drug Conjugate

Lee, Byeong Ill ; Park, Min-Ho ; Byeon, Jin-Ju ; Shin, Seok-Ho ; Choi, Jangmi ; Park, Yuri ; Park, Yun-Hee ; Chae, Jeiwook ; Shin, Young G

Molecules (Basel, Switzerland), 2020-03, Vol.25 (7), p.1515 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
6
HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses
HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses
Material Type:
Artigo 		Adicionar ao Meu Espaço

HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses

Tokuchi, Keiko ; Maeda, Takuya ; Kitamura, Shinya ; Yanagi, Teruki ; Ujiie, Hideyuki

Cancers, 2022-07, Vol.14 (14), p.3519 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
7
Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery
Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery
Material Type:
Artigo 		Adicionar ao Meu Espaço

Making smart drugs smarter: The importance of linker chemistry in targeted drug delivery

Yang, Xiaoxiao ; Pan, Zhixiang ; Choudhury, Manjusha R. ; Yuan, Zhengnan ; Anifowose, Abiodun ; Yu, Bingchen ; Wang, Wenyi ; Wang, Binghe

Medicinal research reviews, 2020-11, Vol.40 (6), p.2682-2713 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
8
Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma
Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma

Fang, Tao ; Duarte, Joao N. ; Ling, Jingjing ; Li, Zeyang ; Guzman, Jonathan S. ; Ploegh, Hidde L.

Angewandte Chemie (International ed.), 2016-02, Vol.55 (7), p.2416-2420 [Periódico revisado por pares]

Germany: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis
Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis

Pawełczyk, Anna ; Sowa-Kasprzak, Katarzyna ; Olender, Dorota ; Zaprutko, Lucjusz

International journal of molecular sciences, 2018-04, Vol.19 (4), p.1104 [Periódico revisado por pares]

Switzerland: MDPI

Texto completo disponível

Citações Citado por
10
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study

Lonial, Sagar ; Lee, Hans C. ; Badros, Ashraf ; Trudel, Suzanne ; Nooka, Ajay K. ; Chari, Ajai ; Abdallah, Al‐Ola ; Callander, Natalie ; Sborov, Douglas ; Suvannasankha, Attaya ; Weisel, Katja ; Voorhees, Peter M. ; Womersley, Lynsey ; Baron, January ; Piontek, Trisha ; Lewis, Eric ; Opalinska, Joanna ; Gupta, Ira ; Cohen, Adam D.

Cancer, 2021-11, Vol.127 (22), p.4198-4212 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (2.728)
  2. Revistas revisadas por pares (2.476)

Autor/Criador 

  1. Jimenez, P  (1)
  2. Costa-Lotufo, L  (1)
  3. Wilke, D  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1994  (21)
  2. 1994Até2003  (18)
  3. 2004Até2010  (75)
  4. 2011Até2018  (1.030)
  5. Após 2018  (2.016)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (3.103)
  2. Japonês  (304)
  3. Chinês  (25)
  4. Francês  (18)
  5. Alemão  (14)
  6. Português  (3)
  7. Coreano  (2)
  8. Polonês  (1)
  9. Russo  (1)
  10. Norueguês  (1)
  11. Espanhol  (1)
  12. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Jimenez, P
  2. Costa-Lotufo, L
  3. Wilke, D

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Antibody-Drug Conjugate
  5. Antibody-Drug Conjugates

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.